Cargando…
Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study
INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT)....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540864/ https://www.ncbi.nlm.nih.gov/pubmed/34877787 http://dx.doi.org/10.1111/1744-9987.13775 |
_version_ | 1784803798024192000 |
---|---|
author | Cui, Yun Shi, Jingyi Lu, Guoping Wang, Ying Zhu, Xiaodong Ren, Hong Zhu, Yueniu Yan, Gangfeng Wang, Chunxia Zhang, Yucai |
author_facet | Cui, Yun Shi, Jingyi Lu, Guoping Wang, Ying Zhu, Xiaodong Ren, Hong Zhu, Yueniu Yan, Gangfeng Wang, Chunxia Zhang, Yucai |
author_sort | Cui, Yun |
collection | PubMed |
description | INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT). METHODS: This multicentered nested case–control study was conducted from 2016 to 2020. The characteristics were compared between survivors and non‐survivors. Logistic regression was applied to identify the risk factors for death. The cutoff values were assessed by receiver operating characteristics curves. RESULTS: Fifty two patients were enrolled in this study. Interleukin‐6 level (p = 0.018) and the number of organ dysfunction (p = 0.047) were independent risk factors for death. The cutoff value of 13.12 pg/ml interleukin‐6 and three organs dysfunction at CRRT initiation presented a high sensitivity and specificity. CONCLUSION: The number of organ dysfunction and interleukin‐6 at CRRT initiation are independent risk factors for death in pediatric patients with SHLH‐associated MODS. |
format | Online Article Text |
id | pubmed-9540864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-95408642022-10-14 Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study Cui, Yun Shi, Jingyi Lu, Guoping Wang, Ying Zhu, Xiaodong Ren, Hong Zhu, Yueniu Yan, Gangfeng Wang, Chunxia Zhang, Yucai Ther Apher Dial Original Articles INTRODUCTION: Multiple organ dysfunction syndrome (MODS) with secondary hemophagocytic lymphohistiocytosis (SHLH) causes significant mortality. We aimed to identify the predictor factors for death in pediatric patients with SHLH‐associated MODS receiving continuous renal replacement therapy (CRRT). METHODS: This multicentered nested case–control study was conducted from 2016 to 2020. The characteristics were compared between survivors and non‐survivors. Logistic regression was applied to identify the risk factors for death. The cutoff values were assessed by receiver operating characteristics curves. RESULTS: Fifty two patients were enrolled in this study. Interleukin‐6 level (p = 0.018) and the number of organ dysfunction (p = 0.047) were independent risk factors for death. The cutoff value of 13.12 pg/ml interleukin‐6 and three organs dysfunction at CRRT initiation presented a high sensitivity and specificity. CONCLUSION: The number of organ dysfunction and interleukin‐6 at CRRT initiation are independent risk factors for death in pediatric patients with SHLH‐associated MODS. John Wiley & Sons Australia, Ltd 2021-12-22 2022-10 /pmc/articles/PMC9540864/ /pubmed/34877787 http://dx.doi.org/10.1111/1744-9987.13775 Text en © 2021 The Authors. Therapeutic Apheresis and Dialysis published by John Wiley & Sons Australia, Ltd on behalf of International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Cui, Yun Shi, Jingyi Lu, Guoping Wang, Ying Zhu, Xiaodong Ren, Hong Zhu, Yueniu Yan, Gangfeng Wang, Chunxia Zhang, Yucai Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title | Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title_full | Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title_fullStr | Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title_full_unstemmed | Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title_short | Prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: A multicenter prospective nested case‐control study |
title_sort | prognostic death factors in secondary hemophagocytic lymphohistiocytosis children with multiple organ dysfunction syndrome receiving continuous renal replacement therapy: a multicenter prospective nested case‐control study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540864/ https://www.ncbi.nlm.nih.gov/pubmed/34877787 http://dx.doi.org/10.1111/1744-9987.13775 |
work_keys_str_mv | AT cuiyun prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT shijingyi prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT luguoping prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT wangying prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT zhuxiaodong prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT renhong prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT zhuyueniu prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT yangangfeng prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT wangchunxia prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy AT zhangyucai prognosticdeathfactorsinsecondaryhemophagocyticlymphohistiocytosischildrenwithmultipleorgandysfunctionsyndromereceivingcontinuousrenalreplacementtherapyamulticenterprospectivenestedcasecontrolstudy |